Bovay lecture to focus on adapting to metabolic stress on March 6
Alan R. Saltiel, PhD, distinguished professor of medicine and pharmacology and the Dr. Maryam Ahmadian Endowed Chair in Metabolic Health at the University of California San Diego, will present the 2026 Harry E. Bovay, Jr. Annual Lecture at 11 a.m. March 6 in the Beth Robertson Auditorium at the Sarofim Research Building.
Saltiel will present “Adapting to Metabolic Stress.”
Saltiel serves as the director of the Institute for Diabetes and Metabolic Health and director of the Diabetes Research Center at University of California San Diego and University of California Los Angeles. He received his PhD in biochemistry from the University of North Carolina in 1980 and completed postdoctoral training with Dr. Pedro Cuatrecasas at the Welcome Research Laboratories in Research Triangle Park, North Carolina, studying mechanisms of insulin action.
He was responsible for preclinical studies on troglitazone, the first thiazolidinedione approved for treatment of Type 2 diabetes and developed the first MEK inhibitors for the treatment of cancer.
Saltiel has received numerous distinctions throughout his career, including the Rosalyn Yalow Research and Development Award from the American Diabetes Association, as well as the Hirschl Award, the John Jacob Abel, and the Goodman and Gilman awards from the American Society of Pharmacology and Experimental Therapeutics. He was elected a fellow of the American Association for the Advancement of Science and elected to membership in the American Society for Clinical Investigation, the National Academy of Medicine, and National Academy of Inventors.
The Harry E. Bovay, Jr. Lecture honors the life and work of Harry E. Bovay Jr., distinguished visionary, entrepreneur, civic leader, and philanthropist, who made a significant contribution to The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases. His contribution helped bridge the gap between laboratory bench and the patient bedside, between identifying the molecular causes of diseases and actually preventing them.